RevBio, Inc.

@RevBio_

RevBio is developing an injectable, self-setting and bioresorbable bone adhesive that can bond bone to bone and bone to metal to stabilize implant devices.

revbio.com

Joined July 2014

RevBio, Inc.
@RevBio_
Mar 6
We’re here at #NASBS2026 Swing by booth 107 to learn how #TETRANITE® regenerative bone adhesive is transforming the future of skull-based procedures by eleminating the need for metal hardware. See a product demo and hear about our upcoming pivotal trial! #RevBio #NASBS
RevBio, Inc.
@RevBio_
Jun 9, 2023
“ The clinical use of this material will reduce the time and complexity of ridge augmentation procedures and likely lead to more consistent results with better volume maintenance of these grafts”
RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone...
From businesswire.com
RevBio, Inc.
@RevBio_
May 22, 2023
Read our newest press release below ⬇️
RevBio Receives ISO 13485 Certification for its Quality Management System
From businesswire.com
RevBio, Inc.
@RevBio_
Mar 21, 2023
RevBio is in Dana Point, CA for LSI 2023 Emerging MedTech Summit. CEO Brian Hess will be presenting Thursday, March 23rd at 10:25 am (PST). We look forward to sharing new and exciting company updates, as well as connecting with potential investors in sunny California!
RevBio, Inc.
@RevBio_
Feb 14, 2023
TETRANITE® is a novel biomaterial technology purpose-designed to reduce the duration and complexity of dental implant procedures. Read the full press release here: businesswire.com/news/home/2023… #TETRANITE #BoneAdhesive #DentalImplant #investment #biomaterials #clinical #PDS #Innovation